Dr. Arthur Agatston Joins Dave Feldman for an In-Depth Conversation on Cardiovascular Health
Dr. Arthur Agatston, preventive cardiologist and developer of the Agatston Calcium Score, joins Dave Feldman on The Feldman Protocol for an in-depth, three-part conversation exploring cardiovascular disease prevention, coronary artery imaging, cholesterol, metabolic health, and the evolving science of assessing heart disease risk.
Across nearly six hours of discussion, Dr. Agatston reflects on the development of the coronary calcium score, what decades of cardiac imaging have taught us about the progression of atherosclerosis, and how advances in imaging and artificial intelligence may help physicians better identify and manage cardiovascular risk.
The three-part series also explores coronary plaque, statin therapy and LDL cholesterol, insulin resistance, HDL function, the origins of the South Beach Diet, and emerging research in cardiovascular prevention.
Watch the Three-Part Conversation
Part 1: The Agatston Score, Coronary Plaque and Heart Attack Prevention
In Part 1, Dr. Agatston discusses the origins of the Agatston Calcium Score and how coronary imaging changed our understanding of atherosclerosis and heart attack risk. The conversation explores coronary calcium, plaque progression, the significance of a calcium score of zero, and the role imaging can play in cardiovascular prevention.
Watch Part 1 Now:
OR get early access and see all three parts now:
Full access to the episodes will require a subscription to The Feldman Protocol Substack.
Part 2: Advanced Cardiac Imaging, Cholesterol and Cardiovascular Risk
Available September 21, 2026
Part 2 continues the conversation with a discussion of the evolution of cardiac imaging, AI-based plaque analysis, the origins of the South Beach Diet, LDL cholesterol, lean mass hyper-responders, and emerging cardiovascular research.
Part 3: Metabolic Health and the Future of Cardiovascular Prevention
Available September 24, 2026
In the final installment, Dr. Agatston and Dave Feldman explore insulin resistance, HDL function, cardiovascular risk factors, and current questions surrounding cholesterol guidelines and heart disease prevention.